Another vaccine fails to prevent staph infections
Staph infections remain a significant problem for hospital patients, and scientists are trying to develop vaccines to prevent Staphylococcus aureus bacteria from establishing itself in vital areas like the heart, lungs or blood. But it's turning out to be a difficult task: A promising vaccine intended to protect heart-surgery patients from staph infections worked no better than a placebo, a new study reported. Making matters worse, patients who developed staph infections despite getting the vaccine were more likely to die than infected patients who got the placebo, the study found.
- mHealth Tackles Readmissions
- 'Kafkaesque' Value System Unfairly Penalizes Doctor Pay
- CNO Leads $1M Charge for New Scrubs, Uniforms
- Targeting Self-Insured Populations
- MA an Insurance Proving Ground for Providers
- Proton Beam Therapy Poised for Growth in US
- Sharp HealthCare Leaves Pioneer ACO Program
- Some Cancer Hospitals' Quality Data Will Soon Be Public
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- Docs Fret as HHS Addresses Malpractice Reporting 'Loopholes'